000 04500nam a22003615i 4500
001 234115
003 ES-VaUE
005 20221220020542.0
007 cr nn 008mamaa
008 141015s2015 xxu| s |||| 0|eng d
020 _a9781493915385
024 7 _a10.1007/978-1-4939-1538-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
245 1 0 _aRNA Interference
_bChallenges and Therapeutic Opportunities
_cedited by Mouldy Sioud.
250 _a1st edition 2015
264 1 _aNew York, NY
_bSpringer International Publishing
_c2015
300 _a1 recurso en línea (XVI, 495 páginas)
_b108 ilustraciones, 58 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v1218
505 0 _aRNA Interference: Mechanisms, Technical Challenges and Therapeutic Opportunities -- Nanostructured RNAs for RNA Interference -- One Long Oligonucleotide or Two Short Oligonucleotides Based shRNA Construction and Expression -- PLGA Microspheres Encapsulating siRNA -- Magnetic Nanoparticle and Magnetic Field Assisted siRNA Delivery In Vitro -- Cytoplasmic Delivery of siRNAs to Monocytes and Dendritic Cells Via Electroporation -- Delivery of siRNAs to Cancer Cells Via Bacteria -- Microwell Array-Mediated Delivery of Lipoplexes Containing Nucleic Acids for Enhanced Therapeutic Efficacy -- Modulating the Tumor Microenvironment with RNA Interference as a Cancer Treatment Strategy -- Targeted In Vivo Delivery of siRNA and an Endosome-Releasing Agent to Hepatocytes -- Cell-Internalization SELEX: Method for Identifying Cell-Internalizing RNA Aptamers for Delivering siRNAs to Target Cells -- Strategies for siRNA Navigation to Desired Cells -- Analysis of RNA Interference-Mediated Hepatic Gene Silencing Following Murine Hydrodynamic Injection of Guanidinopropyl-Modified siRNAs -- Therapy of Respiratory Viral Infections with Intranasal siRNAs -- Engineering Therapeutic Cancer Vaccines that Activate Anti-Tumor Immunity -- Immunosuppressive Factor Blockade in Dendritic Cells Via siRNAs Results in Objective Clinical Responses -- Targeting bcr-abl Transcripts with siRNAs in an Imatinib-Resistant Chronic Myeloid Leukemia Patient: Challenges and Future Directions -- A Facile Method for Interfering with Off-Target Silencing Mediated by the Sense Strand -- Overcoming the Challenges of siRNA Activation of Innate Immunity: Design Better Therapeutic siRNAs -- Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs -- In Silico Identification of Novel Endo-siRNAs -- Computer-Assisted Annotation of Small RNA Transcriptomes -- miR-CATCH: MicroRNA Capture Affinity Technology -- Roles of MicroRNAs in Cancers and Development -- Targeting MicroRNAs to Withstand Cancer Metastasis -- Urinary MicroRNAs as a New Class of Non-Invasive Biomarkers in Oncology, Nephrology and Cardiology -- Magnetic Bead-Based Isolation of Exosomes -- Modified 2'-Ribose Small RNAs Function as Toll-Like Receptor-7/8 Antagonists.
520 _aRNA Interference: Challenges and Therapeutic Opportunities provides readers with recent advances in siRNA design, delivery, targeting, and methods to minimize siRNA's unwanted effects. Preclinical and clinical use of synthetic siRNAs, the roles of miRNAs in cancer, and the promise of extracellular miRNAs for diagnosis are also covered in this meticulous collection, along with novel methods for identifying endogenous siRNAs and the annotation of small RNA transcriptomes. Written for the highly successful Methods in Molecular Biology series, chapters include the kind of detail and key implementation advice that ensures successful results in the laboratory.   Comprehensive and cutting-edge, RNA Interference: Challenges and Therapeutic Opportunities will aid researchers, clinicians, teachers, and biotechnologists interested in the power of RNA-based therapies.
700 1 _aSioud, Mouldy
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9781493915378
776 0 8 _iPrinted edition:
_z9781493915392
776 0 8 _iPrinted edition:
_z9781493948918
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-1538-5
_z(usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
988 _aSpringer_Protocols_2015
999 _c234115
_d234115